Vivos Therapeutics, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

Q: Mar 31 2026

FY: Dec 31 2025

FY: Dec 31 2025

Q: Sep 30 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

FY: Dec 31 2023

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

Changes in Registrant's Certifying Accountant

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Other Events

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Other Events

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Post-effective amendment to a registration statement

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933 (amendment)

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933

Prospectus filed under Rule 424(b)(1)

Notice of Effectiveness

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus filed under Rule 424(b)(1)

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

JOHNSON GREGG C

SOKOLOW LEONARD J

Huntsman Ronald Kirk

Streeterville Capital LLC

Amman Bradford K.

ARMISTICE CAPITAL, LLC

Streeterville Capital LLC

Skaff Michael C

V-Co Investors 4 LLC

V-Co Investors 4 LLC

ARMISTICE CAPITAL, LLC

V-Co Investors 3 LLC

V-Co Investors 3 LLC

Skaff Michael C; V-Co Investors 3 LLC

JOHNSON GREGG C

LUO DAWEI

Skaff Michael C

V-CO Investors LLC

INTRACOASTAL CAPITAL, LLC

V-CO Investors LLC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC